tysabri.nl tysabri.nl

tysabri.nl

Info over behandeling van MS met Tysabri - Tysabri

Homepage : nl-NL

http://www.tysabri.nl/

WEBSITE DETAILS
SEO
PAGES
SIMILAR SITES

TRAFFIC RANK FOR TYSABRI.NL

TODAY'S RATING

>1,000,000

TRAFFIC RANK - AVERAGE PER MONTH

BEST MONTH

November

AVERAGE PER DAY Of THE WEEK

HIGHEST TRAFFIC ON

Friday

TRAFFIC BY CITY

CUSTOMER REVIEWS

Average Rating: 4.5 out of 5 with 11 reviews
5 star
8
4 star
0
3 star
3
2 star
0
1 star
0

Hey there! Start your review of tysabri.nl

AVERAGE USER RATING

Write a Review

WEBSITE PREVIEW

Desktop Preview Tablet Preview Mobile Preview

LOAD TIME

0.9 seconds

CONTACTS AT TYSABRI.NL

Login

TO VIEW CONTACTS

Remove Contacts

FOR PRIVACY ISSUES

CONTENT

SCORE

6.2

PAGE TITLE
Info over behandeling van MS met Tysabri - Tysabri | tysabri.nl Reviews
<META>
DESCRIPTION
Homepage : nl-NL
<META>
KEYWORDS
1 voor patiënten
2 voor zorgverleners
3 bijsluiter tysabri
4 tysabri
5 inloggen patiënt
6 registreer patiënt
7 welkom bij tysabri
8 informatie voor patiënten
9 inloggen voor patiënten
10 informatie voor zorgverleners
CONTENT
Page content here
KEYWORDS ON
PAGE
voor patiënten,voor zorgverleners,bijsluiter tysabri,tysabri,inloggen patiënt,registreer patiënt,welkom bij tysabri,informatie voor patiënten,inloggen voor patiënten,informatie voor zorgverleners,inloggen voor zorgverleners,disclaimer,colofon
SERVER
Microsoft-IIS/8.5
POWERED BY
ASP.NET
CONTENT-TYPE
utf-8
GOOGLE PREVIEW

Info over behandeling van MS met Tysabri - Tysabri | tysabri.nl Reviews

https://tysabri.nl

Homepage : nl-NL

INTERNAL PAGES

tysabri.nl tysabri.nl
1

Inloggen - Tysabri

https://www.tysabri.nl/nl-NL/Patienten/MS-en-het-belang-van-behandelen

De website www.tysabri.nl maakt gebruik van cookies. Meer informatie hierover vindt u in de privacyverklaring onderaan de website. U bepaalt zelf of u cookies accepteert. Bij de instellingen van uw webbrowser kunt u het gebruik van cookies instellen. Accepteren. Please wait a moment. Voer onderstaand uw inloggevens in:. Biogen Netherlands B.V.

2

Bijsluiter Tysabri - Tysabri

https://www.tysabri.nl/nl-NL/Bijsluiter-Tysabri

De website www.tysabri.nl maakt gebruik van cookies. Meer informatie hierover vindt u in de privacyverklaring onderaan de website. U bepaalt zelf of u cookies accepteert. Bij de instellingen van uw webbrowser kunt u het gebruik van cookies instellen. Accepteren. Please wait a moment. Voor de tekst van de bijsluiter van Tysabri. Als u op deze link klikt, verlaat u de Tysabri website. Biogen is niet verantwoordelijk voor de inhoud van de website waar u naar toegaat. Biogen Netherlands B.V.

3

Disclaimer - Tysabri

https://www.tysabri.nl/Pages/nl-NL/Default/Disclaimer

De website www.tysabri.nl maakt gebruik van cookies. Meer informatie hierover vindt u in de privacyverklaring onderaan de website. U bepaalt zelf of u cookies accepteert. Bij de instellingen van uw webbrowser kunt u het gebruik van cookies instellen. Accepteren. Please wait a moment. Lees deze Gebruiksvoorwaarden zorgvuldig voordat u deze website gebruikt. Deze Gebruiksvoorwaarden geven de voorwaarden weer die van toepassing zijn op uw gebruik van de website http:/ www.tysabri.nl. Eigenaar van de website:.

4

Colofon - Tysabri

https://www.tysabri.nl/Pages/nl-NL/Default/Colofon

De website www.tysabri.nl maakt gebruik van cookies. Meer informatie hierover vindt u in de privacyverklaring onderaan de website. U bepaalt zelf of u cookies accepteert. Bij de instellingen van uw webbrowser kunt u het gebruik van cookies instellen. Accepteren. Please wait a moment. Opdrachtgever: Biogen International BV. Biogen Netherlands B.V.

UPGRADE TO PREMIUM TO VIEW 0 MORE

TOTAL PAGES IN THIS WEBSITE

4

OTHER SITES

tysabri-news.blogspot.com tysabri-news.blogspot.com

THE TYSABRI CHANNEL

WE HAVE 2 NEW TYSABRI EDITORS STARTING 4/15/10! THEY WIL BE POSTING TYSABRI NEWS EVERY DAY! Saturday, July 25. NHS Wales Approves Biogen’s Plegridy for Relapsing Remitting MS. New MS Study Shows TYSABRI Improves Cognitive Impairment. Thursday, July 2. Cognitive evolution in Tysabri treated Multiple Sclerosis patients: STUDY. Researchers Suggest Short Transition Period Between Tysabri (Natalizumab) and Gilenya (Fingolimod) Therapies to Control RRMS Disease Activity. An international team led by researcher...

tysabri.co.il tysabri.co.il

Medison

To improve quality of life. Medison is Israel’s leading international marketing group for innovative niche pharmaceuticals, medical devices and diagnostic products. With three generations of experience in the healthcare industry, Medison is uniquely qualified to provide the complete spectrum of integrated services for international companies looking to enter or expand their presence in the Israeli, Romanian and Slovakian healthcare markets. Representing the world’s leading companies, we deliver c...

tysabri.com tysabri.com

Tysabri® (natalizumab)

For US residents only. PATIENT SERVICES 800.456.2255. Data-cycle-fx="scrollHorz" data-cycle-timeout="6000" data-cycle-pager-active-class="active" data-cycle-slide-active-class="active" data-cycle-prev=".previous" data-cycle-next=".next" data-cycle-slides=" div" style="z-index: 0;". Welcome to the Relapsing MS community. Are you ready to unleash your inner fighter? Welcome to the community where thousands of people with relapsing multiple sclerosis (MS) won't let their disease get the best of them. Events...

tysabri.de tysabri.de

Tysabri

Herzlich Willkommen bei TYSABRI. Bitte geben Sie Ihre DocCheck. Aus gesetzlichen Gründen dürfen wir Patienten leider nicht über verschreibungspflichtige Medikamente informieren. Bitte nutzen Sie unser Serviceangebot für Patienten auf www.ms-life.de.

tysabri.msnewschannel.com tysabri.msnewschannel.com

THE TYSABRI CHANNEL

Your browser does not support inline frames or is currently configured not to display inline frames.

tysabri.nl tysabri.nl

Info over behandeling van MS met Tysabri - Tysabri

De website www.tysabri.nl maakt gebruik van cookies. Meer informatie hierover vindt u in de privacyverklaring onderaan de website. U bepaalt zelf of u cookies accepteert. Bij de instellingen van uw webbrowser kunt u het gebruik van cookies instellen. Accepteren. Please wait a moment. Deze website biedt meer informatie over de behandeling van MS (Multiple Sclerose) met Tysabri (natalizumab). De site bestaat uit twee gedeelten:. Biogen Netherlands B.V.

tysabricdspeakers.com tysabricdspeakers.com

Under Construction

The site you are trying to view does not currently have a default page. It may be in the process of being upgraded and configured. Please try this site again later. If you still experience the problem, try contacting the Web site administrator. If you are the Web site administrator and feel you have received this message in error, please see Enabling and Disabling Dynamic Content in IIS Help. To access IIS Help. And then click Run. Text box, type inetmgr. Menu, click Help Topics.

tysabridirect.com tysabridirect.com

Tysabri Direct Home

Frisco, TX 75034. Welcome to TysabriDirect, the portal for access to physician-administered injectable products. You can count on TysabriDirect to provide best in class customer service, with a team dedicated to take your call. Ordering product is quick and easy, allowing you to focus your time on your customers and their needs. For your convenience, orders can be submitted online 24 hours a day. Monday - Friday, 7:30 am - 7:00 pm CT. September 7, 2015. November 26 and 27, 2015. December 25, 2015.

tysabrifdp.com tysabrifdp.com

Login

TYSABRI Free Drug Program. Welcome to TYSABRI Free Drug Ordering Site. This site enables you to order medication for your patients enrolled in the TYSABRI Free Drug Program. For questions about patient eligibility for the TYSABRI Free Drug Program, please call Biogen™ at 1-800-456-2255. For questions about order status or login issues, please call AcariaHealth at 1-855-215-7200. Accredited by The Joint Commission.

tysabriglobalwebcast.com tysabriglobalwebcast.com

TYSABRI Global Webcast

Prof Bernd C. Kieseier. Dept of Neurology, Heinrich Heine University. Prof Per Soelberg Sorensen. Danish Multiple Sclerosis Research Center,. Dept of Neurology, Copenhagen University Hospital,. Rigshospitalet, Copenhagen, Denmark. Department of Clinical Neuroscience. Karolinska Institute, Stockholm, Sweden. Dr Alfred W. Sandrock. SVP, Neurology R&D, Biogen Idec. Broadcasted from Amsterdam, NL. Tuesday May 12, 2009 12:00 CET. Click button below for system requirements:. Registration - click button below:.

tysabrihcp.com tysabrihcp.com

Treatment for Relapsing Multiple Sclerosis

For US healthcare professionals only. TYSABRI Infusion Site Locator. Proposed Mechanism of Action. Proposed Mechanism of Action. To see additional Important Safety Information, including Boxed Warning. On 3 key efficacy parameters as seen in a 2-year study. Who treat relapsing MS and prescribe TYSABRI. A commitment to patient safety with the TOUCH. Find local infusion sites. Authorized to administer TYSABRI. An established therapy with more than 8 years of clinical use in the US. The primary endpoint at ...